Form 4: Royalty Pharma Director Henry A. Fernandez Receives Restricted Stock Units

Director Henry A. Fernandez reports acquisition of Royalty Pharma plc Class A Ordinary Shares through restricted stock units.

Summary

• On May 13, 2025, Henry A. Fernandez, a director of Royalty Pharma plc, acquired 7,614 Class A Ordinary Shares.
• These shares were obtained through an award of restricted stock units under the company's 2020 Independent Director Equity Incentive Plan.
• The restricted stock units are scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date.
• Following the transaction, Mr. Fernandez directly owns 64,260 Class A Ordinary Shares and indirectly owns 58,200 shares through the Fernandez 2007 Children's Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The award of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The vesting of the restricted stock units is contingent upon the terms of the 2020 Independent Director Equity Incentive Plan and the applicable award agreement.

Industry Context

This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with company performance.

Key Dates

Keywords

Royalty Pharma, Director, Henry A. Fernandez, Restricted Stock Units, Class A Ordinary Shares, Beneficial Ownership, Equity Incentive Plan